Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Baidu Inc. A ADR

Start price
Target price
Perf. (%)
€218.28
21.11.17
€140.00
04.11.21
-35.04%
05.11.21

buy
Baidu Inc. A ADR

Start price
Target price
Perf. (%)
€218.28
21.11.17
€140.00
04.11.21
-35.04%
05.11.21

SG Blocks Inc.

Start price
Target price
Perf. (%)
€5.07
25.10.21
-
25.10.22
-34.48%
26.10.21

Could be worthwhile Investment >10% per year
SG Blocks Inc.

Start price
Target price
Perf. (%)
€4.92
25.10.21
-
25.10.22
-35.68%
25.10.21

Risky Investment
buy
SG Blocks Inc.

Start price
Target price
Perf. (%)
€6.85
23.01.21
€0.000
23.01.22
-25.99%
25.10.21

Could be worthwhile Investment >10% per year
buy
GenKyoTex S.A.

Start price
Target price
Perf. (%)
€3.18
28.09.21
€3.60
-
24.10.21

Could be worthwhile Investment >10% per year
buy
It Link S.A.

Start price
Target price
Perf. (%)
€13.35
17.11.19
-
04.11.21
132.21%
18.10.21

Could be worthwhile Investment >10% per year
buy
Marin Software

Start price
Target price
Perf. (%)
€7.15
04.10.21
€14.00
04.10.22
-11.19%
18.10.21

Could be worthwhile Investment >10% per year
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€11.56
21.09.21
€9.00
21.09.22
-13.58%
16.10.21

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€33.94
29.04.21
-
29.04.26
-29.38%
15.10.21

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
AEHR Test Systems

Start price
Target price
Perf. (%)
€10.50
04.10.21
-
04.10.22
48.57%
11.10.21

Revenue growth >5% per year expected
Top 10 in its market
Probably not worthwhile Investment
Little known brand
Signaux Girod

Start price
Target price
Perf. (%)
€15.50
07.09.21
€13.00
07.09.22
1.29%
09.10.21

Could be worthwhile Investment >10% per year
buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.52
29.09.21
€0.75
29.09.22
-20.66%
09.10.21

Could be worthwhile Investment >10% per year
buy
Bridgeline Digital Inc.

Start price
Target price
Perf. (%)
€4.04
30.09.21
-
30.09.22
-15.84%
08.10.21

Risky Investment
buy
Marin Software

Start price
Target price
Perf. (%)
€9.05
24.09.21
€18.00
24.09.22
-20.99%
04.10.21

Could be worthwhile Investment >10% per year
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€675.52
18.09.21
€209.79
18.09.22
-25.47%
02.10.21

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
buy
Marin Software

Start price
Target price
Perf. (%)
€14.90
02.07.21
€18.00
02.07.22
-46.31%
28.09.21

Could be worthwhile Investment >10% per year
buy
Rewalk Robotics Ltd.

Start price
Target price
Perf. (%)
€1.56
21.09.21
€1.00
21.09.22
31.41%
24.09.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
buy
Lysogene SA

Start price
Target price
Perf. (%)
€2.80
05.06.20
€3.30
04.11.21
-18.39%
24.09.21

Could be worthwhile Investment >10% per year
buy
FlexShopper Inc

Start price
Target price
Perf. (%)
€2.08
20.08.21
€6.20
20.08.22
39.42%
22.09.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€9.36
06.11.20
€14.00
06.11.21
23.50%
21.09.21

Could be worthwhile Investment >10% per year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€5.30
13.09.21
-
13.09.22
8.49%
19.09.21

Risky Investment
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€25.20
12.09.21
-
12.09.22
-4.37%
18.09.21

Risky Investment
ClearSign Combustion Corp.

Start price
Target price
Perf. (%)
€1.87
04.09.21
€0.000
04.09.22
2.14%
18.09.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Sphere 3D Corp.

Start price
Target price
Perf. (%)
€38.50
04.09.21
€14.00
04.09.22
-0.91%
18.09.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation